Beone Medicines Ltd. Class A · SSE:688235

Oyler John sold 4,940 Beone Medicines Ltd. Class A shares (Form 4)

Traded Jun 8, 2026 · Filed Jun 10, 2026

On Jun 8, 2026, Oyler John (Director, Chief Executive Officer) sold 4,940 Beone Medicines Ltd. Class A shares at an average US$270.55 for US$1.34M, leaving 0 shares. Filed Jun 10, 2026 (Form 4).

Sold
4,940 shares
Price
US$270.55 average (US$270.38 to US$271.14)
Value
US$1.34M
Holding after
0 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 8, 2026American Depositary SharesSale3,820US$270.381,120Direct
Jun 8, 2026American Depositary SharesSale1,120US$271.140Direct

Source

View original at SEC

Related